The global Paclitaxel market was valued at 8.91 Million USD in
2021 and will grow with a CAGR of 8.72% from 2021 to 2027, based on HNY
Research newly published report.
The prime objective of this report is to provide the insights on the post
COVID-19 impact which will help market players in this field evaluate their
business approaches. Also, this report covers market segmentation by major
market verdors, types, applications/end users and geography(North America, East
Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South
America).
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was
discovered in 1962 as a result of a U.S. National Cancer Institute-funded
screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark
of the Pacific yew, Taxus brevifolia, and named it "taxol".In the
last several years, global market of Paclitaxel developed rapidly, with an
average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly
80 M USD; the actual production is about 2600 Kg. The classification of
Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API,
and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the
proportion is decreasing trend from 2012 to 2017.
By Market Verdors:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
By Types:
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
By Applications:
Ovarian Cancer
Cervical Cancer
Breast Cancer
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of
the industry including Company Profile, Product Specifications, Production
Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a
thorough analysis of the market’s competitive landscape and detailed
information on vendors and comprehensive details of factors that will challenge
the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional
market status and outlook 2016-2027. Further the report provides break down
details about each region & countries covered in the report. Identifying
its sales, sales volume & revenue forecast. With detailed analysis by types
and applications.
Market Trends: Market key trends which include Increased Competition and
Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition
in industry depending on five basic forces: threat of new entrants, bargaining
power of suppliers, bargaining power of buyers, threat of substitute products
or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding
of the global market and its commercial
landscape.
Assess the production processes, major issues, and solutions to mitigate the
development risk.
To understand the most affecting driving and restraining forces in the market
and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective
organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research
according to specific requirements
1
Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Paclitaxel Revenue
1.4 Market Analysis by Type
1.4.1 Global Paclitaxel Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Natural Paclitaxel API
1.4.3 Semi-synthetic Paclitaxel API
1.5 Market by Application
1.5.1 Global Paclitaxel Market Share by Application: 2022-2027
1.5.2 Ovarian Cancer
1.5.3 Cervical Cancer
1.5.4 Breast Cancer
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Paclitaxel Market
1.8.1 Global Paclitaxel Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Paclitaxel Production Capacity Market Share by Manufacturers
(2016-2021)
2.2 Global Paclitaxel Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Paclitaxel Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Paclitaxel Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Paclitaxel Sales Volume Market Share by Region (2016-2021)
3.2 Global Paclitaxel Sales Revenue Market Share by Region (2016-2021)
3.3 North America Paclitaxel Sales Volume
3.3.1 North America Paclitaxel Sales Volume Growth Rate (2016-2021)
3.3.2 North America Paclitaxel Sales Volume Capacity, Revenue, Price and Gross
Margin (2016-2021)
3.4 East Asia Paclitaxel Sales Volume
3.4.1 East Asia Paclitaxel Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Paclitaxel Sales Volume Capacity, Revenue, Price and Gross
Margin (2016-2021)
3.5 Europe Paclitaxel Sales Volume (2016-2021)
3.5.1 Europe Paclitaxel Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin
(2016-2021)
3.6 South Asia Paclitaxel Sales Volume (2016-2021)
3.6.1 South Asia Paclitaxel Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Paclitaxel Sales Volume Capacity, Revenue, Price and Gross
Margin (2016-2021)
3.7 Southeast Asia Paclitaxel Sales Volume (2016-2021)
3.7.1 Southeast Asia Paclitaxel Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Paclitaxel Sales Volume Capacity, Revenue, Price and Gross
Margin (2016-2021)
3.8 Middle East Paclitaxel Sales Volume (2016-2021)
3.8.1 Middle East Paclitaxel Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Paclitaxel Sales Volume Capacity, Revenue, Price and Gross
Margin (2016-2021)
3.9 Africa Paclitaxel Sales Volume (2016-2021)
3.9.1 Africa Paclitaxel Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin
(2016-2021)
3.10 Oceania Paclitaxel Sales Volume (2016-2021)
3.10.1 Oceania Paclitaxel Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Paclitaxel Sales Volume Capacity, Revenue, Price and Gross
Margin (2016-2021)
3.11 South America Paclitaxel Sales Volume (2016-2021)
3.11.1 South America Paclitaxel Sales Volume Growth Rate (2016-2021)
3.11.2 South America Paclitaxel Sales Volume Capacity, Revenue, Price and Gross
Margin (2016-2021)
3.12 Rest of the World Paclitaxel Sales Volume (2016-2021)
3.12.1 Rest of the World Paclitaxel Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Paclitaxel Sales Volume Capacity, Revenue, Price and
Gross Margin (2016-2021)
4 North America
4.1 North America Paclitaxel Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Paclitaxel Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Paclitaxel Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Paclitaxel Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Paclitaxel Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Paclitaxel Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Paclitaxel Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Paclitaxel Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Paclitaxel Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Paclitaxel Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Paclitaxel Sales Volume Market Share by Type (2016-2021)
14.2 Global Paclitaxel Sales Revenue Market Share by Type (2016-2021)
14.3 Global Paclitaxel Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Paclitaxel Consumption Volume by Application (2016-2021)
15.2 Global Paclitaxel Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Paclitaxel Business
16.1 Phyton
16.1.1 Phyton Company Profile
16.1.2 Phyton Paclitaxel Product Specification
16.1.3 Phyton Paclitaxel Production Capacity, Revenue, Price and Gross Margin
(2016-2021)
16.2 ScinoPharm
16.2.1 ScinoPharm Company Profile
16.2.2 ScinoPharm Paclitaxel Product Specification
16.2.3 ScinoPharm Paclitaxel Production Capacity, Revenue, Price and Gross
Margin (2016-2021)
16.3 Novasep
16.3.1 Novasep Company Profile
16.3.2 Novasep Paclitaxel Product Specification
16.3.3 Novasep Paclitaxel Production Capacity, Revenue, Price and Gross Margin
(2016-2021)
16.4 Samyang
16.4.1 Samyang Company Profile
16.4.2 Samyang Paclitaxel Product Specification
16.4.3 Samyang Paclitaxel Production Capacity, Revenue, Price and Gross Margin
(2016-2021)
16.5 Polymed
16.5.1 Polymed Company Profile
16.5.2 Polymed Paclitaxel Product Specification
16.5.3 Polymed Paclitaxel Production Capacity, Revenue, Price and Gross Margin
(2016-2021)
16.6 TAPI (Teva)
16.6.1 TAPI (Teva) Company Profile
16.6.2 TAPI (Teva) Paclitaxel Product Specification
16.6.3 TAPI (Teva) Paclitaxel Production Capacity, Revenue, Price and Gross
Margin (2016-2021)
16.7 Fresenius-kabi
16.7.1 Fresenius-kabi Company Profile
16.7.2 Fresenius-kabi Paclitaxel Product Specification
16.7.3 Fresenius-kabi Paclitaxel Production Capacity, Revenue, Price and Gross
Margin (2016-2021)
16.8 Huiang biopharma
16.8.1 Huiang biopharma Company Profile
16.8.2 Huiang biopharma Paclitaxel Product Specification
16.8.3 Huiang biopharma Paclitaxel Production Capacity, Revenue, Price and
Gross Margin (2016-2021)
16.9 Southpharma
16.9.1 Southpharma Company Profile
16.9.2 Southpharma Paclitaxel Product Specification
16.9.3 Southpharma Paclitaxel Production Capacity, Revenue, Price and Gross
Margin (2016-2021)
16.10 Yunnan Hande
16.10.1 Yunnan Hande Company Profile
16.10.2 Yunnan Hande Paclitaxel Product Specification
16.10.3 Yunnan Hande Paclitaxel Production Capacity, Revenue, Price and Gross
Margin (2016-2021)
16.11 Hainan Yew Pharm
16.11.1 Hainan Yew Pharm Company Profile
16.11.2 Hainan Yew Pharm Paclitaxel Product Specification
16.11.3 Hainan Yew Pharm Paclitaxel Production Capacity, Revenue, Price and
Gross Margin (2016-2021)
16.12 Jiangsu Yew Biotechnology
16.12.1 Jiangsu Yew Biotechnology Company Profile
16.12.2 Jiangsu Yew Biotechnology Paclitaxel Product Specification
16.12.3 Jiangsu Yew Biotechnology Paclitaxel Production Capacity, Revenue,
Price and Gross Margin (2016-2021)
17 Paclitaxel Manufacturing Cost Analysis
17.1 Paclitaxel Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Paclitaxel
17.4 Paclitaxel Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Paclitaxel Distributors List
18.3 Paclitaxel Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Paclitaxel (2022-2027)
20.2 Global Forecasted Revenue of Paclitaxel (2022-2027)
20.3 Global Forecasted Price of Paclitaxel (2016-2027)
20.4 Global Forecasted Production of Paclitaxel by Region (2022-2027)
20.4.1 North America Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.3 Europe Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.7 Africa Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.9 South America Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Paclitaxel Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type
(2022-2027)
20.5.2 Global Forecasted Consumption of Paclitaxel by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Paclitaxel by Country
21.2 East Asia Market Forecasted Consumption of Paclitaxel by Country
21.3 Europe Market Forecasted Consumption of Paclitaxel by Countriy
21.4 South Asia Forecasted Consumption of Paclitaxel by Country
21.5 Southeast Asia Forecasted Consumption of Paclitaxel by Country
21.6 Middle East Forecasted Consumption of Paclitaxel by Country
21.7 Africa Forecasted Consumption of Paclitaxel by Country
21.8 Oceania Forecasted Consumption of Paclitaxel by Country
21.9 South America Forecasted Consumption of Paclitaxel by Country
21.10 Rest of the world Forecasted Consumption of Paclitaxel by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
The global market size of Surveillance Cameras
is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to
reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024.
Global Surveillance Cameras Market Report 2019 - Market Size, Share, Price,
Trend and Forecast is a professional and in-depth study on the current state of
the global Surveillance Cameras industry. The key insights of the report:
1.The report provides key statistics on the market status of the Surveillance
Cameras manufacturers and is a valuable source of guidance and direction for
companies and individuals interested in the industry.
2.The report provides a basic overview of the industry including its
definition, applications and manufacturing technology.
3.The report presents the company profile, product specifications, capacity,
production value, and 2013-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by
application/type for the competitive landscape analysis.
5.The report estimates 2019-2024 market development trends of Surveillance
Cameras industry.
6.Analysis of upstream raw materials, downstream demand, and current market
dynamics is also carried out
7.The report makes some important proposals for a new project of Surveillance
Cameras Industry before evaluating its feasibility.
There are 4 key segments covered in this report: competitor segment, product
type segment, end use/application segment and geography segment.
For competitor segment, the report includes global key players of Surveillance
Cameras as well as some small players. At least 18 companies are included:
* Sony
* AXIS
* Vaddio
* Panasonic
* Pelco
* Canon
For complete companies list, please ask
for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Surveillance
Cameras market
* Ordinary Type
* Moon Type
* Starlight Type
* Infrared Lighting Type
For end use/application segment, this report focuses on the status and outlook
for key applications. End users sre also listed.
* Application I
* Application II
* Application III
For geography segment, regional supply, application-wise and type-wise demand,
major players, price is presented from 2013 to 2023. This report covers
following regions:
* North America
* South America
* Asia & Pacific
* Europe
* MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as
United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy,
Spain, CIS, and Brazil etc.
Reasons to Purchase this Report:
* Analyzing the outlook of the market
with the recent trends and SWOT analysis
* Market dynamics scenario, along with
growth opportunities of the market in the years to come
* Market segmentation analysis including
qualitative and quantitative research incorporating the impact of economic and
non-economic aspects
* Regional and country level analysis
integrating the demand and supply forces that are influencing the growth of the
market.
* Market value (USD Million) and volume
(Units Million) data for each segment and sub-segment
* Competitive landscape involving the
market share of major players, along with the new projects and strategies
adopted by players in the past five years
* Comprehensive company profiles
covering the product offerings, key financial information, recent developments,
SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the
data support in excel format.
We also can offer customized report to fulfill special requirements of our
clients. Regional and Countries report
can be provided as well.
The global market size of Milk Infant Formula is
$XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach
$XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024.
Global Milk Infant Formula Market Report 2019 - Market Size, Share, Price, Trend
and Forecast is a professional and in-depth study on the current state of the
global Milk Infant Formula industry. The key insights of the report:
1.The report provides key statistics on the market status of the Milk Infant
Formula manufacturers and is a valuable source of guidance and direction for
companies and individuals interested in the industry.
2.The report provides a basic overview of the industry including its
definition, applications and manufacturing technology.
3.The report presents the company profile, product specifications, capacity,
production value, and 2013-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by
application/type for the competitive landscape analysis.
5.The report estimates 2019-2024 market development trends of Milk Infant
Formula industry.
6.Analysis of upstream raw materials, downstream demand, and current market
dynamics is also carried out
7.The report makes some important proposals for a new project of Milk Infant
Formula Industry before evaluating its feasibility.
There are 4 key segments covered in this report: competitor segment, product
type segment, end use/application segment and geography segment.
For competitor segment, the report includes global key players of Milk Infant
Formula as well as some small players. At least 16 companies are included:
* DGC
* Danone
* Ausnutria Dairy
* Baiyue youlishi
* YaTai-Precious
* Red Star
For complete companies list, please ask
for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Milk Infant
Formula market
* SMP
* WMP
* Whey Powders
* Others
For end use/application segment, this report focuses on the status and outlook
for key applications. End users sre also listed.
* 0~6 months baby
* 6~12 months baby
* 1~3 years baby
For geography segment, regional supply, application-wise and type-wise demand,
major players, price is presented from 2013 to 2023. This report covers
following regions:
* North America
* South America
* Asia & Pacific
* Europe
* MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as
United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy,
Spain, CIS, and Brazil etc.
Reasons to Purchase this Report:
* Analyzing the outlook of the market
with the recent trends and SWOT analysis
* Market dynamics scenario, along with
growth opportunities of the market in the years to come
* Market segmentation analysis including
qualitative and quantitative research incorporating the impact of economic and
non-economic aspects
* Regional and country level analysis
integrating the demand and supply forces that are influencing the growth of the
market.
* Market value (USD Million) and volume
(Units Million) data for each segment and sub-segment
* Competitive landscape involving the
market share of major players, along with the new projects and strategies
adopted by players in the past five years
* Comprehensive company profiles
covering the product offerings, key financial information, recent developments,
SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the
data support in excel format.
We also can offer customized report to fulfill special requirements of our
clients. Regional and Countries report
can be provided as well.